Primary pulmonary hypertension (PPH) is a serious disease associated with a high mortality both in pregnancy and childbirth, as well as during surgery and anaesthesia l -4 • This paper describes a patient with severe PPH awaiting heart-lung transplantation, who underwent successful termination of pregnancy and laparoscopic sterilisation.
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CASE HISTORY
A 33-year-old, 53 kg multigravid woman with severe PPH presented at eight weeks' gestation for suction termination of pregnancy because of the adverse prognosis associated with continuation of pregnancy in women with PPH. Her PPH had been diagnosed six months previously, following an eight-month period of exertional dyspnoea and lethargy. She had recently been placed on the heart-lung transplantation waiting list. When informed about future risk of pregnancy she also agreed to laparoscopic tuballigation. Other past history included depression, heavy smoking and alcohol consumption; she had a concurrent E.coli urinary tract infection.
Her current therapy included warfarin (ceased three days before surgery), nifedipine and co-trimoxazole. Preoperative clinical examination revealed an anxious woman with clear lung fields, a loud second heart sound and no murmurs. A chest X-ray demonstrated clear lung fields and prominent pulmonary outflow tracts. A twelve-lead electrocardiograph demonstrated a sinus tachycardia (loo/min) with right axis deviation, right atrial and right ventricular hypertrophy. Haemoglobin concentration was 124 g/litre, her clotting normal (INR = 1.2) and arterial blood gases in room air were: pH 7.41, PaC0 2 38 mmHg, P a 0 2 84 mmHg and Sa02 970/0. A recent transthoracic echocardiography showed a normal left ventricle with good contractility, right atrial and ventricular hypertrophy with dilatation, with mild tricuspid and pulmonary regurgitation. No atrial septal defect was seen. The pulmonary artery systolic pressure was estimated at 90 mmHg. A gated blood pool scan also demonstrated typical features of pulmonary hypertension, with right ventricular overload and ejection fraction of 51 %. A ventilation-perfusion lung scan excluded pulmonary embolism.
After premedication with O.3M sodium citrate, she was transferred to theatre. Peripheral intravenous, radial arterial and internal jugular pulmonary artery catheters were inserted before induction of anaesthesia, for invasive monitoring and administration of vasoactive agents. Infusions of isoprenaline (15 ng/kg/min) and prostacyclin (4 ng/kg/min) were commenced before induction of anaesthesia, with adrenaline and glyceryl trinitrate infusions available if required. Monitoring included pulse oximetry and measurement of endtidal carbon dioxide (C0 2 ) and isoflurane.
After a three-minute period of preoxygenation, anaesthesia was induced with fentanyl 500 mcg, midazolam 5 mg and increments of thiopentone (to 125 mg). Muscle relaxation was achieved with vecuronium 6 mg. Anaesthesia was maintained with 0.5% isoflurane and oxygen, with further increments of thiopentone (to 200 mg). No nitrous oxide was used. Antibiotics were also given (gentamicin and cephazolin); no oxytocics were administered.
Both systemic and pulmonary artery blood pressures remained stable during anaesthesia (see Table 1 ), though there was a transient rise after induction, which responded to further thiopentone and an increase in the prostacyclin infusion rate. There were some brief periods of unifocal ventricular ectopy and bigeminy, which were not specifically treated.
Laparoscopic insufflation with C02 was limited to an intra-abdominal pressure of 15 mmHg. At the end of the procedure, which took 45 minutes, muscle relaxation was reversed with neostigmine 1.25 mg and glycopyrrolate 0.2 mg. The patient was extubated and electively monitored in the recovery room for four hours. Prostacyclin was weaned from 10 ng/kg/min to 7 ng/kg/min. Intramuscular pethidine 75 mg and metoclopramide 10 mg were given for abdominal pain.
The transplant unit was contacted for ongoing management in the general ward; they requested that the prostacyclin infusion be continued because of a perceived risk of rebound pulmonary hypertension. The pulmonary artery catheter was removed and the patient's central venous pressure monitored on the ward. The prostacyclin infusion was decreased slowly over the next 36 hours and the patient discharged the following day. The patient was still awaiting heart-lung transplantation at 18 months.
DISCUSSION
PPH is defined as pulmonary hypertension (mean PAP > 25 mmHg) in the absence of an underlying cause and usually leads to death two to five years from diagnosis'. Although anticoagulation and vasodilator therapy have improved quality of life, the only definitive treatment at present is heart-lung or lung transplantation'. There are many reports of sudden death or cardiac arrest associated with anaesthesia, cardiac catheterisation, radiological procedures and pregnancyl4. In Victoria PPH is a regular cause of mortality in the annual Maternal and Perinatal Mortality reports.
PPH leads to right ventricular hypertrophy and eventually right ventricular failure ( Figure 1 ).2,4,6.
Acute rises in pulmonary pressure, as occurs at induction, may precipitate right ventricular failure and cause shift of the interventricular septum, as well as reduce left ventricular filling, thus decreasing left ventricular output. This reduces coronary blood flow, particularly to the right coronary artery because of the high right ventricular wall tension. Thus a vicious circle ensues with myocardial ischaemia further impeding right ventricular function. It is thought that sinus node ischaemia may aggravate hypoxia-induced bradycardia, leading to irretrievable cardiac arrest'.
Successful anaesthesia and surgery in patients with PPH requires accurate preoperative assessment and invasive haemodynamic monitoring to guide fluid, inotrope and vasodilator therapy. Avoidance of factors that may worsen pulmonary hypertension or decrease ventricular function are also important: relative hypovolaemia, depressant anaesthetic agents, hypoxia, acidosis, hypothermia, arrythmias, stress and pain 4 ,69. Laparoscopic insufflation may be added to this list, either because of the effect on venous return and systemic vascular resistance (SVR) or associated arrhythmias lO ,ll.
Despite the increasing number of reports concerning PPH, there is a paucity of literature describing successful anaesthesia and surgery4,6-9. Intravenous prostacyclin and adenosine have been shown to be particularly useful in terminal or unresponsive cases and also as a "bridge to transplantation" 12-15. More recently, inhaled nitric oxide '6 and nebulised prostacyclin 17 have been described as being more selective pulmonary vasodilators. Isoprenaline was used in this patient because of the known risk of bradyarrhythmias with laparoscopy18, which may have been particularly detrimental (Figure 1 ). TABLE 1 Haemodynamic changes associated with anaesthesia for suction termination of pregnancy (STOP) and laparoscopic sterilisation, in a patient with PPH treated with prostacyC/in and isoprenaline. The preinduction values were measured after stabilisation on prostacyclin and isoprenaline. This patient had severe PPH and despite intravenous prostacyclin therapy being commenced before induction of anaesthesia, had some increase in her pulmonary hypertension during the procedure. Although arguable, this may have risen further during insufflation with carbon dioxide without prostacyclin and isoprenaline therapy. There was no evidence of right ventricular failure, with normal central venous pressure and elevated cardiac output. Criteria for a specific pulmonary vasodilator effect include PVR falling more than SVR 1 9 or an increased cardiac output associated with a decrease in mean pulmonary artery pressureD. In this patient there was a slight fall in PVR after induction of anaesthesia and a significant increase in cardiac output. Hence the prostacyclin infusion was not increased further to reduce PVR.
The accuracy of measuring cardiac output in a patient with tricuspid incompetence, albeit mild, can be questioned. The thermodilution technique was used, with each measurement performed in triplicate at endexpiration using 10 ml of room temperature saline. It is likely that the mild degree of tricuspid incompetence would be further reduced, given the decrease in baseline PVR.
A general anaesthetic technique was chosen for this patient to avoid the haemodynamic effects associated Hypoxia & Acidosis t T CVP with major regional blockade. She was also very anxious, so an awake technique may have increased her circulating catecholamines and potentially exacerbated her pulmonary hypertension. A titrated epidural block to T4 would significantly compromise right ventricular filling and may precipitate the scenario described in Figure 1 . However, such a technique may be suitable for some patients. Spinal anaesthesia would be relatively contraindicated because of the more rapid haemodynamic shifts that may occur.
Some anaesthetists would not invasively monitor such a patient nor alter their anaesthetic technique, arguing that the period of anaesthesia is brief and the level of surgical stress mild. However, it is likely that such an approach has led to serious patient morbidity and mortality in the past. Patients with PPH often appear surprisingly well, yet are at high risk of sudden deterioration. They should not be underestimated.
Pregnancy is associated with many physiological alterations, including a 20 to 300/0 increase in basal metabolic rate and cardiac output, with a decrease in SVR. It is likely that the deterioration seen in patients with PPH during pregnancy is due to these increased metabolic demands'. Such changes are maximal during the mid-trimester, but even at eight weeks' gestation this patient would have been exposed to some physiological alterations. This patient agreed to laparoscopic sterilisation after the risks of pregnancy associated with PPH were explained and because she did not want to have more children. Future pregnancy, and indeed termination, would have been of greater risk in advanced stages of PPH. Until recently, laparoscopy has been a procedure used in young, healthy gynaecological patients. There is now increasing experience and knowledge in patients with advanced cardiorespiratory disease, particularly for cholecystectomy, where it has become the procedure of choice lO • Laparoscopy involves both the Trendelenburg position and intraperitoneal insufflation with carbon dioxide. The effects on pulmonary pressures are unclear from previous studies, though haemodynamic effects vary with intra-abdominal pressure. Johannsen et aJ21 found that peritoneal insufflation to 15 mmHg produced a decrease in cardiac index, with an increase in SVR. This would obviously be detrimental to patients with PPH. Cunningham et alii performed transoesophageal echocardiography during laparoscopic cholecystectomy in a group of healthy patients. They found that left ventricular ejection fraction was maintained, but that end-systolic wall stress was increased during insufflation. Peak airway pressures also rose. However, these results may not be applicable to patients with impaired myocardial function or pulmonary hypertension, particularly in the gynaecological setting of Trendelenburg tilt.
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Arrhythmias are also common with laparoscopy, exacerbated by the higher levels of C0218. Although uncommon, C02 embolism could impose a significant load onto an already strained right ventricle. Monitoring of endtidal C02 may not reflect arterial levels in patients with cardiopulmonary disease. Some authors would therefore suggest that arterial blood should be sampled to accurately monitor arterial CO 2 tension. In this patient endtidal capnography was used to guide ventilator settings; because the procedure was of short duration an arterial sample was not taken. Longer laparoscopic procedures, such as cholecystectomy, warrant more frequent arterial samples.
Isoflurane was chosen in this patient to minimise pulmonary vasoconstriction which may occur with nitrous oxide. Cheng and Edelist 8 demonstrated that isoflurane lowered PVR in a patient with PPH undergoing open lung biopsy. No oxytocic was used because of reports of deterioration following their use 4 ; there was minimal uterine bleeding after evacuation.
It should be remembered that the risk for patients with PPH extend into the postoperative period. Factors that increase PVR should be avoided or minimised (e.g., pain, hypoxia, hypercapnia) and the patient monitored in a suitable environment.
In conclusion, this case report describes successful intraoperative management of a patient with severe PPH. To the author's knowledge, it is the first published report of such a patient undergoing a laparoscopic procedure. The risks for these patients are substantial. Thorough preoperative assessment, invasive monitoring and use of potent pulmonary vasodilators can minimise these risks.
